Probe-based Confocal Laser Endomicroscopy for In Vivo Assessment of Histological Healing in Ulcerative Colitis: Development and Validation of the ENHANCE Index.


Journal

Journal of Crohn's & colitis
ISSN: 1876-4479
Titre abrégé: J Crohns Colitis
Pays: England
ID NLM: 101318676

Informations de publication

Date de publication:
22 Jun 2021
Historique:
pubmed: 19 12 2020
medline: 15 12 2021
entrez: 18 12 2020
Statut: ppublish

Résumé

Histological healing may represent the ultimate therapeutic goal in ulcerative colitis [UC], but it requires biopsies. Our aim was to develop a non-invasive index able to assess histological disease activity in ulcerative colitis, using probe-based confocal laser endomicroscopy [pCLE]. One hundred patients with quiescent UC were prospectively included in five French centres. After fluorescein intravenous injection, during colonoscopy, the colorectal mucosa was analysed by white light imaging and pCLE, and then biopsied in different locations. Five endoscopists performed central reading of pCLE images blinded to clinical, endoscopic, and histological data. One expert pathologist performed a central histological reading [Nancy index: gold standard]. Univariate and multivariate analyses were performed to identify the endomicroscopic items associated with the presence of histologically active disease. Over 1000 pCLE videos sequences performed in 100 UC patients in endoscopic remission [Mayo 0 and 1] were evaluated. We observed that vessel diameter >20 µm, dilated crypt lumen, fluorescein leakage, and irregular crypt architecture were statistically associated with histologically proven inflammation according to the Nancy index. Hence, we built a pCLE index of mucosal inflammation with overall accuracy of 79.6% and overall sensitivity and specificity of, respectively, 57.8% and 82.8%. Negative predictive value, especially when a pCLE index ≤1 was observed, was high [93.1%]. Using a robust methodology, large vessel diameter, dilated crypt lumen, fluorescein leakage,and irregular crypt architecture are reliable endomicroscopic items defining the ENHANCE index for real-time assessment of histological disease activity in UC.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Histological healing may represent the ultimate therapeutic goal in ulcerative colitis [UC], but it requires biopsies. Our aim was to develop a non-invasive index able to assess histological disease activity in ulcerative colitis, using probe-based confocal laser endomicroscopy [pCLE].
METHODS METHODS
One hundred patients with quiescent UC were prospectively included in five French centres. After fluorescein intravenous injection, during colonoscopy, the colorectal mucosa was analysed by white light imaging and pCLE, and then biopsied in different locations. Five endoscopists performed central reading of pCLE images blinded to clinical, endoscopic, and histological data. One expert pathologist performed a central histological reading [Nancy index: gold standard]. Univariate and multivariate analyses were performed to identify the endomicroscopic items associated with the presence of histologically active disease.
RESULTS RESULTS
Over 1000 pCLE videos sequences performed in 100 UC patients in endoscopic remission [Mayo 0 and 1] were evaluated. We observed that vessel diameter >20 µm, dilated crypt lumen, fluorescein leakage, and irregular crypt architecture were statistically associated with histologically proven inflammation according to the Nancy index. Hence, we built a pCLE index of mucosal inflammation with overall accuracy of 79.6% and overall sensitivity and specificity of, respectively, 57.8% and 82.8%. Negative predictive value, especially when a pCLE index ≤1 was observed, was high [93.1%].
CONCLUSIONS CONCLUSIONS
Using a robust methodology, large vessel diameter, dilated crypt lumen, fluorescein leakage,and irregular crypt architecture are reliable endomicroscopic items defining the ENHANCE index for real-time assessment of histological disease activity in UC.

Identifiants

pubmed: 33336249
pii: 6041240
doi: 10.1093/ecco-jcc/jjaa255
doi:

Types de publication

Journal Article Multicenter Study Observational Study Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

994-999

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Gabriel Rahmi (G)

Hepato-Gastroenterology and Digestive Endoscopy Department, Georges Pompidou European Hospital, APHP Centre-Université de Paris, Paris, France.

Emmanuel Coron (E)

CHU Nantes, Institut des Maladies de l'Appareil Digestif [IMAD], University of Nantes, Nantes, France.

Guillaume Perrod (G)

Hepato-Gastroenterology and Digestive Endoscopy Department, Georges Pompidou European Hospital, APHP Centre-Université de Paris, Paris, France.

Michael Levy (M)

Department of Hepato-Gastroenterology, Henri Mondor Hospital, Université Paris Est, Paris, France.

Jacques Moreau (J)

Department of Hepato-Gastroenterology, Rangueil Hospital, CHU Toulouse, Toulouse, France.

Driffa Moussata (D)

Department of Hepato-Gastroenterology, CHU Tours, Tours, France.

Enrique Perez-Cuadrado-Robles (E)

Hepato-Gastroenterology and Digestive Endoscopy Department, Georges Pompidou European Hospital, APHP Centre-Université de Paris, Paris, France.

Antoine Chupin (A)

Hepato-Gastroenterology and Digestive Endoscopy Department, Georges Pompidou European Hospital, APHP Centre-Université de Paris, Paris, France.

Lucille Quénéhervé (L)

CHU Nantes, Institut des Maladies de l'Appareil Digestif [IMAD], University of Nantes, Nantes, France.

Arnaud Bourreille (A)

CHU Nantes, Institut des Maladies de l'Appareil Digestif [IMAD], University of Nantes, Nantes, France.

Aude Marchal (A)

Department of Pathology, CHU Reims, Reims, France.

Christophe Cellier (C)

Hepato-Gastroenterology and Digestive Endoscopy Department, Georges Pompidou European Hospital, APHP Centre-Université de Paris, Paris, France.

Laurent Peyrin-Biroulet (L)

Department of Gastroenterology, University Hospital of Nancy-Brabois, Lorraine University, Vandœuvre-lès-Nancy, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH